Related Experiment Video
Updated: Aug 14, 2026

Mouse Models of Periventricular Leukomalacia
Published on: May 19, 2010
Fetal metachromatic leukodystrophy: pathology, biochemistry and a study of in vitro enzyme replacement in CNS tissue
Abstract:
Brain tissue from a fetus with the diagnosis of metachromatic leukodystrophy (MLD) became available at autopsy. Pathologic studies of the CNS showed inclusion bodies within oligodendroglia. The morphology of myelin was normal. Cells and myelin were isolated from the cerebrum; there was an increased level of sulfatide present in both fractions. In vitro studies of enzyme replacement in cultured MLD brain cells indicated that it may be possible to correct the abnormal sulfatide accumulation.
Insights
Metachromatic leukodystrophy (MLD) involves abnormal sulfatide buildup in brain cells. Enzyme replacement therapy in cultured MLD brain cells shows promise for correcting this accumulation.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Metachromatic leukodystrophy (MLD) is a rare genetic disorder affecting the central nervous system (CNS).
- It is characterized by the accumulation of specific lipids called sulfatides.
- MLD leads to progressive damage of the myelin sheath, which insulates nerve fibers.
Observation:
- Autopsy brain tissue from a fetus diagnosed with MLD was examined.
- Pathological studies revealed characteristic inclusion bodies within oligodendroglia cells in the CNS.
- Myelin morphology appeared normal despite the MLD diagnosis.
Findings:
- Cerebral cells and myelin were isolated for biochemical analysis.
- Both isolated cell and myelin fractions exhibited elevated levels of sulfatides.
- In vitro experiments demonstrated that enzyme replacement could potentially correct abnormal sulfatide accumulation in cultured MLD brain cells.
Implications:
- These findings suggest a potential therapeutic strategy for MLD using enzyme replacement.
- Understanding sulfatide accumulation mechanisms is crucial for developing effective MLD treatments.
- Further research into in vitro enzyme replacement could pave the way for clinical applications in MLD patients.
More Related Videos
07:45An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
11:42In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
Published on: June 10, 2021